MFRF has provided leadership and raised approximately $2.5 million of funding for projects spanning its mission and vision across three pillars: Research of Treatments and Cures, Education and Genetic Screening, and care through Nursing School Educational programs.
MFRF has celebrated wonderful progress in education, genetic testing, and gene therapy patient trials for many affected children and families with fatal genetic diseases of the brain
THE MATHEW FORBES ROMER FOUNDATION’S ANNUAL “EVENING OF SWEETNESS & LAUGHTER” GALA RAISES OVER $60,000
Emotional Event Celebrates Boca Raton Rabbi and Massachusetts Doctor ...
Read More Kevin Romer Elected President of National Tay-Sachs and Allied Diseases Association
Co-Founder and President of 12-Year-Old South Florida Education and ...
Read More 
South Florida Jewish Genetic Diseases Educational and Screening Fair Providing Valuable Screening on May 1
BOCA RATON, FL (March 14, 2011) – The Victor Center ...
Read More 
An Evening Of Sweetness & Laughter Helps Raise More Than $45,000 For The Mathew Forbes Romer Foundation
Drs. Deborah Barbouth and Miguel Sena-Esteves Honored with the “See ...
Read More 
Parents Share Personal Loss Stories and Lessons Learned at South Florida Jewish Genetic Diseases Educational and Screening Fair
Attendance Doubles from Previous Year's Event BOCA RATON, ...
Read More South Florida Jewish Genetic Diseases Educational and Screening Fair Providing Valuable Testing for Free on February 21st
BOCA RATON, FL (January 22, 2010) Kevin and Lisajane ...
Read More Kevin Romer Elected Executive V.P. of National Tay-Sachs and Allied Diseases Association
Co-Founder and President of 10-Year-Old South Florida Education and ...
Read More The Mathew Forbes Romer Foundation Raises More Than $60,000 Celebrating it’s 10th Anniversary “Evening of Sweetness & Laughter”
Judy Levis Markhoff honored with the “See the Light” ...
Read More || OUR STORIES ||
MFRF has celebrated
wonderful progress in gene therapy patient trials, education, and genetic testing for many affected children and families with fatal genetic diseases of the brain. Still, there is so much more to do, including earlier detection and expanding treatment availability.
